C
VRTX icon

Covestor’s Vertex Pharmaceuticals VRTX Stock Holding History

Covestor’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
368
+65
+21% +$28.8K 0.11% 149
2026
Q1 		$136K Sell
303
-181
-37% -$84.4K 0.09% 175
2025
Q4 		$220K Buy
484
+262
+118% +$113K 0.12% 182
2025
Q3 		$87K Sell
222
-76
-26% -$31.8K 0.05% 657
2025
Q2 		$133K Buy
298
+12
+4% +$5.53K 0.08% 385
2025
Q1 		$139K Buy
286
+17
+6% +$7.92K 0.09% 297
2024
Q4 		$109K Sell
269
-415
-61% -$192K 0.07% 478
2024
Q3 		$318K Sell
684
-22
-3% -$10.6K 0.2% 48
2024
Q2 		$331K Buy
706
+298
+73% +$129K 0.21% 46
2024
Q1 		$171K Sell
408
-315
-44% -$133K 0.11% 223
2023
Q4 		$295K Sell
723
-116
-14% -$42.9K 0.2% 44
2023
Q3 		$292K Sell
839
-118
-12% -$41.3K 0.22% 44
2023
Q2 		$337K Sell
957
-75
-7% -$25.3K 0.26% 35
2023
Q1 		$326K Buy
1,032
+44
+4% +$13.2K 0.28% 36
2022
Q4 		$285K Buy
988
+61
+7% +$18.6K 0.23% 57
2022
Q3 		$268K Buy
927
+98
+12% +$28.2K 0.24% 51
2022
Q2 		$234K Sell
829
-226
-21% -$60.5K 0.19% 87
2022
Q1 		$275K Buy
1,055
+159
+18% +$37.7K 0.18% 77
2021
Q4 		$197K Buy
+896
New +$174K 0.28% 33

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Covestor's VRTX Position: Q2 2026 in Review

Covestor increased its Vertex Pharmaceuticals (VRTX) stake by 21% in Q2 2026, buying an estimated $28.8K and bringing the position to 368 shares worth $183K. The position accounts for 0.11% of the portfolio, ranked #149.

Covestor first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $337K in Q2 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Covestor held 368 shares of Vertex Pharmaceuticals worth $183K as of Q2 2026.
  • Covestor bought 65 Vertex Pharmaceuticals shares in Q2 2026, an estimated $28.8K.
  • Vertex Pharmaceuticals made up 0.11% of Covestor's portfolio in Q2 2026, its #149 holding.
  • Covestor first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Vertex Pharmaceuticals position peaked at $337K in Q2 2023.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.